Masimo Corporation (NASDAQ:MASI) Given Average Rating of “Hold” by Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have been assigned a consensus rating of “Hold” from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $189.40.

MASI has been the subject of a number of research reports. BTIG Research boosted their target price on Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Bank of America began coverage on shares of Masimo in a research report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective for the company. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Monday, December 1st. Finally, Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, October 14th.

Masimo Stock Down 1.8%

Shares of MASI opened at $136.62 on Thursday. Masimo has a fifty-two week low of $125.94 and a fifty-two week high of $194.88. The company’s fifty day moving average is $137.56 and its two-hundred day moving average is $144.01. The firm has a market cap of $7.34 billion, a PE ratio of -12.96, a price-to-earnings-growth ratio of 1.41 and a beta of 1.26. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The business had revenue of $371.20 million during the quarter, compared to the consensus estimate of $366.89 million. During the same period in the prior year, the firm posted $0.86 EPS. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. Analysts forecast that Masimo will post 4.1 earnings per share for the current year.

Hedge Funds Weigh In On Masimo

Hedge funds and other institutional investors have recently bought and sold shares of the stock. MAI Capital Management grew its position in Masimo by 176.7% in the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 129 shares in the last quarter. Torren Management LLC acquired a new position in shares of Masimo during the fourth quarter worth $35,000. Smartleaf Asset Management LLC boosted its stake in shares of Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 136 shares during the period. Kohmann Bosshard Financial Services LLC acquired a new stake in Masimo during the 4th quarter valued at $44,000. Finally, Advisory Services Network LLC purchased a new stake in Masimo during the 3rd quarter worth $46,000. 85.96% of the stock is owned by institutional investors and hedge funds.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.